Get the Daily Brief
Latest Biotech News
Biotech Fundraising Outlook: Omega Upsizes to $647M Eighth Fund
Investment firm Omega has significantly increased its eighth biotech fund to $647 million, nearing the size of its prior fund. This fundraising success signals continued investor appetite and...
Emerging Parkinson’s Research: Glymphatic Asymmetry and Novel Therapies
New studies illuminate asymmetry in the brain's glymphatic system as a correlate to the side of Parkinson’s disease symptom onset, advancing understanding of neurodegenerative mechanisms....
Breakthroughs in Molecular and Cellular Oncology Diagnostics and Therapeutics
Recent oncology advances reveal a novel PROTAC-based selective estrogen receptor degrader, vepdegestrant, outperforming fulvestrant in mutant ER-positive breast cancer, offering improved...
Innovations in Genomics and Computational Biology: AI and Single-Cell Technologies
Cutting-edge developments bridge genomics and AI, including a new plain-language hypothesis grammar enabling prediction of multicellular behavior and facilitating virtual cell laboratories....
Sustainable Agriculture and Bio-based Farming Advances Across Continents
European farmers and foresters collaborate to scale bio-based sustainable farming practices, leveraging local expertise for continental transition towards greener agriculture. Innovations in...
Microbial and Viral Mechanisms Illuminate Infection and Immunity
Research uncovers the key role of desmocollin 2 in Epstein–Barr virus epithelial cell entry, advancing understanding of EBV-related malignancies. Novel insights reveal an anti-phage bacterial...
Advances in Flexible Electronics and Biomaterials Engineering
Researchers achieve durable, flexible organic electrochemical transistors using electropolymerized PEDOT, advancing wearable electronic devices. A new biodegradable conductive fiber integrating...
Regulatory and Industry Movements: FDA Flu Vaccine Strategy and Biotech Market Dynamics
The FDA is developing a new framework for flu vaccines aimed at addressing challenges with strain selection and efficacy variability year-to-year. Meanwhile, multiple insurers reduce or withdraw...
FDA and EMA Scrutinize Sarepta’s Duchenne Gene Therapy
Sarepta Therapeutics faces intensified regulatory scrutiny following multiple patient deaths linked to its Duchenne muscular dystrophy gene therapy, Elevidys. The FDA is actively investigating an...
AstraZeneca’s Leadership and Strategic Moves
Bristol Myers Squibb appointed AstraZeneca's Cristian Massacesi as its new chief medical officer starting August 1, aiming to leverage his experience in oncology and rare diseases to bolster its...
AI Advancements in Immunotherapy and Cell Modeling
Researchers at Cold Spring Harbor Laboratory developed BATCAVE, a comprehensive database of over 22,000 TCR-peptide interactions, and an AI model named BATMAN that predicts T cell receptor...
Climate and Sustainability in Food and Agriculture
Recent studies highlight innovative approaches addressing climate change challenges and agricultural sustainability. Integration of renewable energy is enabling improved food sustainability in the...
Innovations in Flexible and Sustainable Electronics
Breakthroughs in materials science have advanced flexible and wearable electronics with robust, high-performance organic electrochemical transistors (OECTs) via electropolymerized PEDOT....
Oncology Advances: Lifestyle, Molecular Targets, and Clinical Guidelines
Growing evidence supports integrating lifestyle interventions into oncology practice, showing benefits in recurrence reduction, mortality improvements, and cost savings. Novel therapies emerge...
Parkinson’s Disease: Neurobiology and Novel Therapeutics
Recent research unveils key mechanisms of Parkinson’s disease, linking glymphatic system asymmetry to symptom lateralization, and distinguishing distinct pathways in nigral and cortical brain...
Biopharma Financing and Industry Trends
Biopharma fundraising remains robust, with significant capital raised in public and private financings year-to-date and substantial recent funds closing, including Brandon Capital's AU$439 million...
Genomics and Multiomics Innovations
Prominent leaders and researchers discuss advances in genomics and multiomics technologies, including spatial proteomics for precision oncology and scaling single-cell genomics projects to enhance...
Regulatory and Market Developments in Drug Approvals and Devices
Regulatory agencies continue making pivotal decisions affecting drug pipelines and medical devices. The EMA’s CHMP adopts five orphan drugs while rejecting Sarepta's Elevidys. Bayer's menopause...
Sarepta’s Elevidys Faces Regulatory Setbacks and Safety Concerns
Sarepta Therapeutics’ Duchenne muscular dystrophy gene therapy, Elevidys, is encountering significant regulatory and safety challenges in both Europe and the U.S. The European Medicines Agency's...
EMA Advances Alzheimer’s and HIV Therapies Amid Mixed Decisions
The European Medicines Agency's CHMP has shown support for Eli Lilly's Alzheimer’s drug Kisunla after reversing an earlier rejection, approving it for patients who are APOE4 heterozygotes or...